CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2012; 33(02): 126-129
DOI: 10.4103/0971-5851.99753
CASE REPORT

Angiosarcoma of the scalp associated with Xeroderma pigmentosum

Shilpi Sharma
Department of Head and Neck Surgical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Anuja D Deshmukh
Department of Head and Neck Surgical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Munita M Bal
Department of Pathology, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Devendra A Chaukar
Department of Head and Neck Surgical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Anil K Dcruz
Department of Head and Neck Surgical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
› Author Affiliations

Abstract

Xeroderma pigmentosum (XP) is a rare autosomal recessive genodermatosis associated with hypersensitivity to ultraviolet light due to defects in Deoxyribonucleic acid (DNA) repair. These patients have more than a 1000-fold increased risk of developing skin cancers. Although multiple cutaneous malignancies are common, the simultaneous occurrence of angiosarcoma and basal cell carcinoma is a rare phenomenon. We report a case of a 25-year-old male with XP with angiosarcoma scalp and basal cell carcinoma of face and occiput and discuss the treatment of this aggressive neoplasm with a review of the literature pertaining to it.



Publication History

Article published online:
13 April 2022

© 2012. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Leake J, Sheehan MP, Rampling D, Ramani P, Atherton DJ. Angiosarcoma complicating xeroderma pigmentosum. Histopathology 1992;21:179-81.
  • 2 De Silva BD, Nawroz I, Doherty VR. Angiosarcoma of the head and neck associated with xeroderma pigmentosum variant. Br J Dermatol 1999;141:166-7.
  • 3 Ludolph-Hauser D, Thomas CE, Sander C, Sommerhoff CP, Rocken M. Mast cells in an angiosarcoma complicating Xeroderma pigmentosum in a 13-year-old girl. J Am Acad Dermatol 2000;43:900-2.
  • 4 Marcon I, Collini P, Casanova M, Meazza C, Ferrari A. Cutaneous angiosarcoma in a patient with Xeroderma pigmentosum. Pediatr Hematol Oncol 2004;21:23-6.
  • 5 Arora R, Sharma A, Gupta R, Vijyaraghavan M. Cutaneous angiosarcoma in a patient with xeroderma pigmentosum. Indian J Pathol Microbiol 2008;51:504-6.
  • 6 Yang XJ, Zheng JW, Zhou Q, Ye WM, Wang YA, Zhu HG, et al. Angiosarcomas of the head and neck: A clinic-immunohistochemical study of 8 consecutive patients. Int. J. Oral Maxillofac Surg 2010; 39:568-72.
  • 7 Arlett CF, Plowman PN, Rogers PB, Parris CN, Abbaszadeh F, McMillan TJ, et al. Clinical and cellular ionizing radiation sensitivity in a patient with xeroderma pigmentosum. Br J Radiol 2006;79:510-17.
  • 8 Girard C, Johnson WC, Graham JH. Cutaneous angiosarcoma. Cancer 1970;26:868-83.
  • 9 Mark RJ, Poen JC, Tran LM, Fu YS, Juillard GF. Angiosarcoma. A report of 67 patients and a review of the literature. Cancer 1996;77:2400-6.
  • 10 Fata F, O′Reilly E, Llson D, Pfister D, Leffel D, Kelsen DP, et al. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer 1999;86:2034-7.
  • 11 Nagano T, Yamada Y, Ikeda T, Kanki H, Kamo T, Nishigori C. Docetaxel: A therapeutic option in the treatment of cutaneous angiosarcoma: Report of 9 patients. Cancer 2007;110:648-51.
  • 12 Holden CA, Spittle MF, Wilson Jones E. Angiosarcoma of the face and scalp: Prognosis and treatment. Cancer 1987;59:1046-57.
  • 13 Lydiatt WM, Shaha AR, Shah JP. Angiosarcoma of the head and neck. Am J Surg 1994;168:451-4.